#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endometrial cancer recurrent Ataxia telangiectasia Pleural mesothelioma malignant Hyperinsulinaemic hypoglycaemia Castleman's disease Lennox-Gastaut syndrome Advanced systemic mastocytosis Squamous cell carcinoma of head and neck Piriformis syndrome Immunodeficiency common variable Lung adenocarcinoma Frontotemporal dementia Sarcoidosis Neuroendocrine carcinoma of the skin HER2 mutant non-small cell lung cancer More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma – Trials in Disease Chondrosarcoma metastatic – Treatment Rhabdomyosarcoma recurrent – Diagnostics Myelodysplastic syndrome with excess blasts – Life with Disease Glomerulonephritis membranous – Treatment Mastocytosis – Treatment Mantle cell lymphoma stage II Hereditary motor and sensory neuropathy – Trials in Disease Breast angiosarcoma metastatic Wiskott-Aldrich syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dermatophagoides Farinae Ciclesonide Obefazimod IM-101 Flutemetamol (18F) Darolutamide Ergocalciferol Bp Casimersen Iptacopan Hydrochloride Gs-4182 Metoclopramide TIFCEMALIMAB MZE829 Vinblastine Sulfate Montelukast Sodium Acetazolamide Sodium Romidepsin Aceclofenac Cloxacillin Sodium Keto-Isoleucine Calcium More therapies…

    Learn about Your Condition

    Fibrosarcoma metastatic Thyroid disorder Eosinophilic gastritis Melanoma recurrent Colon cancer metastatic Exudative retinopathy Oesophageal atresia Lymphocytic lymphoma Idiopathic pulmonary fibrosis Device related infection Dermatitis atopic Partial lipodystrophy Haemorrhoids Placenta praevia Ophthalmoplegia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on the Long-term Safety of Vedolizumab for Children with Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    Hungary Poland

  • Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Rosnilimab
    Austria Bulgaria Croatia France Germany Italy +4

  • Study on Aprepitant for Preventing Nausea and Vomiting After Bariatric Surgery in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Aprepitant
    Estonia

  • Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Zibotentan
    Belgium Czechia Germany Italy Poland Slovakia

  • Study on Dexlansoprazole for Treating and Maintaining Healing of Erosive Esophagitis in Children Aged 2 to 11 Years

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Erosive oesophagitis
    Investigated Drugs:
    • Dexlansoprazole
    Poland
Previous Page
1 … 74 75 76 77 78 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!